nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—Mitomycin—stomach cancer	0.141	0.257	CbGbCtD
Ketamine—CYP2B6—Irinotecan—stomach cancer	0.0704	0.129	CbGbCtD
Ketamine—CYP2C9—Capecitabine—stomach cancer	0.0602	0.11	CbGbCtD
Ketamine—CYP2C8—Fluorouracil—stomach cancer	0.0511	0.0935	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—stomach cancer	0.0384	0.0703	CbGbCtD
Ketamine—ABCB1—Irinotecan—stomach cancer	0.0361	0.0659	CbGbCtD
Ketamine—CYP2C9—Fluorouracil—stomach cancer	0.0357	0.0652	CbGbCtD
Ketamine—TACR1—vagus nerve—stomach cancer	0.0272	0.32	CbGeAlD
Ketamine—ABCB1—Docetaxel—stomach cancer	0.0264	0.0483	CbGbCtD
Ketamine—CYP3A4—Irinotecan—stomach cancer	0.0216	0.0395	CbGbCtD
Ketamine—ABCB1—Doxorubicin—stomach cancer	0.0197	0.036	CbGbCtD
Ketamine—ABCB1—Methotrexate—stomach cancer	0.0191	0.0349	CbGbCtD
Ketamine—CYP3A4—Docetaxel—stomach cancer	0.0158	0.029	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—stomach cancer	0.0118	0.0216	CbGbCtD
Ketamine—Nystagmus—Floxuridine—stomach cancer	0.00965	0.0816	CcSEcCtD
Ketamine—Obstructive airways disorder—Methotrexate—stomach cancer	0.00515	0.0436	CcSEcCtD
Ketamine—TACR1—hematopoietic system—stomach cancer	0.00443	0.0523	CbGeAlD
Ketamine—TACR1—smooth muscle tissue—stomach cancer	0.00391	0.0461	CbGeAlD
Ketamine—Nystagmus—Fluorouracil—stomach cancer	0.00315	0.0266	CcSEcCtD
Ketamine—TACR1—digestive system—stomach cancer	0.00308	0.0364	CbGeAlD
Ketamine—Erythema—Floxuridine—stomach cancer	0.00301	0.0255	CcSEcCtD
Ketamine—GRIN1—endocrine gland—stomach cancer	0.00279	0.0329	CbGeAlD
Ketamine—GRIN2B—endocrine gland—stomach cancer	0.00266	0.0314	CbGeAlD
Ketamine—TACR1—endocrine gland—stomach cancer	0.00255	0.0301	CbGeAlD
Ketamine—Anaphylactic shock—Floxuridine—stomach cancer	0.00246	0.0208	CcSEcCtD
Ketamine—OPRM1—hematopoietic system—stomach cancer	0.00246	0.029	CbGeAlD
Ketamine—Erythema—Mitomycin—stomach cancer	0.00236	0.02	CcSEcCtD
Ketamine—Anorexia—Floxuridine—stomach cancer	0.00234	0.0198	CcSEcCtD
Ketamine—GRIN2A—endocrine gland—stomach cancer	0.00232	0.0274	CbGeAlD
Ketamine—Salivary hypersecretion—Irinotecan—stomach cancer	0.00228	0.0193	CcSEcCtD
Ketamine—PTGS1—blood vessel—stomach cancer	0.00225	0.0266	CbGeAlD
Ketamine—Vision blurred—Mitomycin—stomach cancer	0.00223	0.0188	CcSEcCtD
Ketamine—Decreased appetite—Floxuridine—stomach cancer	0.00214	0.0181	CcSEcCtD
Ketamine—Shock—Mitomycin—stomach cancer	0.0019	0.016	CcSEcCtD
Ketamine—Anorexia—Mitomycin—stomach cancer	0.00184	0.0155	CcSEcCtD
Ketamine—TACR1—lymph node—stomach cancer	0.00176	0.0208	CbGeAlD
Ketamine—Decreased appetite—Mitomycin—stomach cancer	0.00168	0.0142	CcSEcCtD
Ketamine—Pain—Mitomycin—stomach cancer	0.00165	0.0139	CcSEcCtD
Ketamine—Vomiting—Floxuridine—stomach cancer	0.00156	0.0132	CcSEcCtD
Ketamine—Rash—Floxuridine—stomach cancer	0.00155	0.0131	CcSEcCtD
Ketamine—Dermatitis—Floxuridine—stomach cancer	0.00155	0.0131	CcSEcCtD
Ketamine—Nystagmus—Epirubicin—stomach cancer	0.00153	0.013	CcSEcCtD
Ketamine—CYP2C8—hematopoietic system—stomach cancer	0.00148	0.0174	CbGeAlD
Ketamine—Nausea—Floxuridine—stomach cancer	0.00146	0.0123	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—stomach cancer	0.00142	0.012	CcSEcCtD
Ketamine—OPRM1—endocrine gland—stomach cancer	0.00141	0.0167	CbGeAlD
Ketamine—Apnoea—Methotrexate—stomach cancer	0.00138	0.0117	CcSEcCtD
Ketamine—ABCB1—blood vessel—stomach cancer	0.00133	0.0157	CbGeAlD
Ketamine—CYP2B6—hematopoietic system—stomach cancer	0.00133	0.0156	CbGeAlD
Ketamine—CYP2C9—hematopoietic system—stomach cancer	0.00131	0.0155	CbGeAlD
Ketamine—Vomiting—Mitomycin—stomach cancer	0.00123	0.0104	CcSEcCtD
Ketamine—Rash—Mitomycin—stomach cancer	0.00122	0.0103	CcSEcCtD
Ketamine—Dermatitis—Mitomycin—stomach cancer	0.00122	0.0103	CcSEcCtD
Ketamine—Bradycardia—Irinotecan—stomach cancer	0.0012	0.0101	CcSEcCtD
Ketamine—PTGS1—hematopoietic system—stomach cancer	0.0012	0.0141	CbGeAlD
Ketamine—Nausea—Mitomycin—stomach cancer	0.00115	0.00969	CcSEcCtD
Ketamine—Cystitis noninfective—Methotrexate—stomach cancer	0.00114	0.00966	CcSEcCtD
Ketamine—Diplopia—Capecitabine—stomach cancer	0.00114	0.00965	CcSEcCtD
Ketamine—Cystitis—Methotrexate—stomach cancer	0.00113	0.00955	CcSEcCtD
Ketamine—PTGS1—epithelium—stomach cancer	0.0011	0.0129	CbGeAlD
Ketamine—Cystitis noninfective—Epirubicin—stomach cancer	0.00107	0.00904	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—stomach cancer	0.00106	0.00899	CcSEcCtD
Ketamine—Bladder pain—Methotrexate—stomach cancer	0.00106	0.00894	CcSEcCtD
Ketamine—Cystitis—Epirubicin—stomach cancer	0.00106	0.00894	CcSEcCtD
Ketamine—PTGS1—smooth muscle tissue—stomach cancer	0.00106	0.0125	CbGeAlD
Ketamine—Arrhythmia—Irinotecan—stomach cancer	0.00105	0.00891	CcSEcCtD
Ketamine—SLC6A2—endocrine gland—stomach cancer	0.00103	0.0122	CbGeAlD
Ketamine—Arrhythmia—Fluorouracil—stomach cancer	0.00101	0.00853	CcSEcCtD
Ketamine—CYP3A4—hematopoietic system—stomach cancer	0.001	0.0118	CbGeAlD
Ketamine—Bladder pain—Epirubicin—stomach cancer	0.00099	0.00837	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—stomach cancer	0.00099	0.00837	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—stomach cancer	0.000984	0.00832	CcSEcCtD
Ketamine—Erythema—Fluorouracil—stomach cancer	0.000983	0.00831	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—stomach cancer	0.000978	0.00827	CcSEcCtD
Ketamine—DRD2—endocrine gland—stomach cancer	0.000942	0.0111	CbGeAlD
Ketamine—CYP2B6—lymphoid tissue—stomach cancer	0.000933	0.011	CbGeAlD
Ketamine—Vision blurred—Fluorouracil—stomach cancer	0.000927	0.00783	CcSEcCtD
Ketamine—CYP2B6—digestive system—stomach cancer	0.000922	0.0109	CbGeAlD
Ketamine—Bladder pain—Doxorubicin—stomach cancer	0.000916	0.00774	CcSEcCtD
Ketamine—CYP2C9—digestive system—stomach cancer	0.000913	0.0108	CbGeAlD
Ketamine—Convulsion—Fluorouracil—stomach cancer	0.000852	0.0072	CcSEcCtD
Ketamine—CYP2C8—endocrine gland—stomach cancer	0.000849	0.01	CbGeAlD
Ketamine—Anaphylactic shock—Irinotecan—stomach cancer	0.000838	0.00708	CcSEcCtD
Ketamine—PTGS1—digestive system—stomach cancer	0.000834	0.00983	CbGeAlD
Ketamine—Shock—Irinotecan—stomach cancer	0.000824	0.00697	CcSEcCtD
Ketamine—Bradycardia—Capecitabine—stomach cancer	0.000804	0.00679	CcSEcCtD
Ketamine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000802	0.00678	CcSEcCtD
Ketamine—Anorexia—Irinotecan—stomach cancer	0.000799	0.00675	CcSEcCtD
Ketamine—Diplopia—Epirubicin—stomach cancer	0.000795	0.00672	CcSEcCtD
Ketamine—Hypotension—Irinotecan—stomach cancer	0.000783	0.00662	CcSEcCtD
Ketamine—CYP2C8—liver—stomach cancer	0.000766	0.00903	CbGeAlD
Ketamine—Anorexia—Fluorouracil—stomach cancer	0.000765	0.00647	CcSEcCtD
Ketamine—CYP2B6—endocrine gland—stomach cancer	0.000762	0.00899	CbGeAlD
Ketamine—CYP2C9—endocrine gland—stomach cancer	0.000754	0.0089	CbGeAlD
Ketamine—Hypotension—Fluorouracil—stomach cancer	0.00075	0.00634	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—stomach cancer	0.000735	0.00622	CcSEcCtD
Ketamine—Decreased appetite—Irinotecan—stomach cancer	0.000728	0.00616	CcSEcCtD
Ketamine—Arrhythmia—Docetaxel—stomach cancer	0.000728	0.00616	CcSEcCtD
Ketamine—Pain—Irinotecan—stomach cancer	0.000716	0.00606	CcSEcCtD
Ketamine—SLC6A2—lymph node—stomach cancer	0.000715	0.00843	CbGeAlD
Ketamine—Erythema—Docetaxel—stomach cancer	0.00071	0.006	CcSEcCtD
Ketamine—ABCB1—hematopoietic system—stomach cancer	0.000709	0.00836	CbGeAlD
Ketamine—Arrhythmia—Capecitabine—stomach cancer	0.000705	0.00596	CcSEcCtD
Ketamine—Decreased appetite—Fluorouracil—stomach cancer	0.000698	0.0059	CcSEcCtD
Ketamine—CYP3A4—digestive system—stomach cancer	0.000696	0.00821	CbGeAlD
Ketamine—PTGS1—endocrine gland—stomach cancer	0.000689	0.00813	CbGeAlD
Ketamine—Erythema—Capecitabine—stomach cancer	0.000687	0.00581	CcSEcCtD
Ketamine—CYP2B6—liver—stomach cancer	0.000687	0.0081	CbGeAlD
Ketamine—Pain—Fluorouracil—stomach cancer	0.000686	0.0058	CcSEcCtD
Ketamine—CYP2C9—liver—stomach cancer	0.00068	0.00803	CbGeAlD
Ketamine—ABCB1—epithelium—stomach cancer	0.000648	0.00764	CbGeAlD
Ketamine—Vision blurred—Capecitabine—stomach cancer	0.000648	0.00547	CcSEcCtD
Ketamine—Convulsion—Docetaxel—stomach cancer	0.000615	0.0052	CcSEcCtD
Ketamine—Anaphylactic shock—Docetaxel—stomach cancer	0.000579	0.0049	CcSEcCtD
Ketamine—ABCB1—pancreas—stomach cancer	0.000577	0.00681	CbGeAlD
Ketamine—CYP3A4—endocrine gland—stomach cancer	0.000575	0.00679	CbGeAlD
Ketamine—Shock—Docetaxel—stomach cancer	0.00057	0.00482	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—stomach cancer	0.00056	0.00473	CcSEcCtD
Ketamine—Anorexia—Docetaxel—stomach cancer	0.000552	0.00467	CcSEcCtD
Ketamine—Shock—Capecitabine—stomach cancer	0.000552	0.00466	CcSEcCtD
Ketamine—Hypotension—Docetaxel—stomach cancer	0.000541	0.00458	CcSEcCtD
Ketamine—Anorexia—Capecitabine—stomach cancer	0.000535	0.00452	CcSEcCtD
Ketamine—Vomiting—Irinotecan—stomach cancer	0.000533	0.0045	CcSEcCtD
Ketamine—Rash—Irinotecan—stomach cancer	0.000528	0.00447	CcSEcCtD
Ketamine—Dermatitis—Irinotecan—stomach cancer	0.000528	0.00446	CcSEcCtD
Ketamine—Hypotension—Capecitabine—stomach cancer	0.000524	0.00443	CcSEcCtD
Ketamine—CYP3A4—liver—stomach cancer	0.000519	0.00612	CbGeAlD
Ketamine—Bradycardia—Doxorubicin—stomach cancer	0.000518	0.00438	CcSEcCtD
Ketamine—Erythema—Methotrexate—stomach cancer	0.000511	0.00432	CcSEcCtD
Ketamine—Vomiting—Fluorouracil—stomach cancer	0.00051	0.00431	CcSEcCtD
Ketamine—Rash—Fluorouracil—stomach cancer	0.000506	0.00428	CcSEcCtD
Ketamine—Dermatitis—Fluorouracil—stomach cancer	0.000505	0.00427	CcSEcCtD
Ketamine—Decreased appetite—Docetaxel—stomach cancer	0.000503	0.00426	CcSEcCtD
Ketamine—ABCB1—lymphoid tissue—stomach cancer	0.000499	0.00589	CbGeAlD
Ketamine—Nausea—Irinotecan—stomach cancer	0.000498	0.00421	CcSEcCtD
Ketamine—Pain—Docetaxel—stomach cancer	0.000495	0.00419	CcSEcCtD
Ketamine—ABCB1—digestive system—stomach cancer	0.000493	0.00581	CbGeAlD
Ketamine—Arrhythmia—Epirubicin—stomach cancer	0.000491	0.00415	CcSEcCtD
Ketamine—Decreased appetite—Capecitabine—stomach cancer	0.000487	0.00412	CcSEcCtD
Ketamine—Vision blurred—Methotrexate—stomach cancer	0.000482	0.00408	CcSEcCtD
Ketamine—Pain—Capecitabine—stomach cancer	0.00048	0.00405	CcSEcCtD
Ketamine—Erythema—Epirubicin—stomach cancer	0.000479	0.00405	CcSEcCtD
Ketamine—Nausea—Fluorouracil—stomach cancer	0.000477	0.00403	CcSEcCtD
Ketamine—PTGS1—lymph node—stomach cancer	0.000476	0.00562	CbGeAlD
Ketamine—Arrhythmia—Doxorubicin—stomach cancer	0.000455	0.00384	CcSEcCtD
Ketamine—ABCB1—bone marrow—stomach cancer	0.000454	0.00536	CbGeAlD
Ketamine—Vision blurred—Epirubicin—stomach cancer	0.000451	0.00381	CcSEcCtD
Ketamine—Convulsion—Methotrexate—stomach cancer	0.000443	0.00375	CcSEcCtD
Ketamine—Erythema—Doxorubicin—stomach cancer	0.000443	0.00374	CcSEcCtD
Ketamine—Anaphylactic shock—Methotrexate—stomach cancer	0.000417	0.00353	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—stomach cancer	0.000417	0.00353	CcSEcCtD
Ketamine—Convulsion—Epirubicin—stomach cancer	0.000415	0.00351	CcSEcCtD
Ketamine—ABCB1—endocrine gland—stomach cancer	0.000407	0.0048	CbGeAlD
Ketamine—Anorexia—Methotrexate—stomach cancer	0.000398	0.00336	CcSEcCtD
Ketamine—Anaphylactic shock—Epirubicin—stomach cancer	0.000391	0.0033	CcSEcCtD
Ketamine—Hypotension—Methotrexate—stomach cancer	0.00039	0.0033	CcSEcCtD
Ketamine—Shock—Epirubicin—stomach cancer	0.000384	0.00325	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—stomach cancer	0.000384	0.00324	CcSEcCtD
Ketamine—Anorexia—Epirubicin—stomach cancer	0.000372	0.00315	CcSEcCtD
Ketamine—Vomiting—Docetaxel—stomach cancer	0.000368	0.00311	CcSEcCtD
Ketamine—ABCB1—liver—stomach cancer	0.000367	0.00433	CbGeAlD
Ketamine—Rash—Docetaxel—stomach cancer	0.000365	0.00309	CcSEcCtD
Ketamine—Hypotension—Epirubicin—stomach cancer	0.000365	0.00309	CcSEcCtD
Ketamine—Dermatitis—Docetaxel—stomach cancer	0.000365	0.00308	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—stomach cancer	0.000363	0.00307	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000361	0.00306	CcSEcCtD
Ketamine—Pain—Methotrexate—stomach cancer	0.000357	0.00302	CcSEcCtD
Ketamine—Vomiting—Capecitabine—stomach cancer	0.000357	0.00301	CcSEcCtD
Ketamine—Shock—Doxorubicin—stomach cancer	0.000356	0.00301	CcSEcCtD
Ketamine—Rash—Capecitabine—stomach cancer	0.000354	0.00299	CcSEcCtD
Ketamine—Dermatitis—Capecitabine—stomach cancer	0.000353	0.00299	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—stomach cancer	0.000345	0.00291	CcSEcCtD
Ketamine—Nausea—Docetaxel—stomach cancer	0.000344	0.00291	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—stomach cancer	0.00034	0.00287	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—stomach cancer	0.000338	0.00286	CcSEcCtD
Ketamine—Pain—Epirubicin—stomach cancer	0.000334	0.00282	CcSEcCtD
Ketamine—Nausea—Capecitabine—stomach cancer	0.000333	0.00282	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—stomach cancer	0.000314	0.00266	CcSEcCtD
Ketamine—Pain—Doxorubicin—stomach cancer	0.000309	0.00261	CcSEcCtD
Ketamine—ABCB1—lymph node—stomach cancer	0.000281	0.00332	CbGeAlD
Ketamine—Vomiting—Methotrexate—stomach cancer	0.000265	0.00224	CcSEcCtD
Ketamine—Rash—Methotrexate—stomach cancer	0.000263	0.00223	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—stomach cancer	0.000263	0.00222	CcSEcCtD
Ketamine—Vomiting—Epirubicin—stomach cancer	0.000248	0.0021	CcSEcCtD
Ketamine—Nausea—Methotrexate—stomach cancer	0.000248	0.0021	CcSEcCtD
Ketamine—Rash—Epirubicin—stomach cancer	0.000246	0.00208	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—stomach cancer	0.000246	0.00208	CcSEcCtD
Ketamine—Nausea—Epirubicin—stomach cancer	0.000232	0.00196	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—stomach cancer	0.00023	0.00194	CcSEcCtD
Ketamine—Rash—Doxorubicin—stomach cancer	0.000228	0.00193	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—stomach cancer	0.000228	0.00193	CcSEcCtD
Ketamine—Nausea—Doxorubicin—stomach cancer	0.000215	0.00182	CcSEcCtD
Ketamine—OPRD1—Signaling by GPCR—KRAS—stomach cancer	1.81e-05	7.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRB2—stomach cancer	1.8e-05	7.19e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKR1C3—stomach cancer	1.77e-05	7.1e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPP2R1A—stomach cancer	1.77e-05	7.07e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.77e-05	7.07e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK3—stomach cancer	1.76e-05	7.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IRS2—stomach cancer	1.76e-05	7.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	1.76e-05	7.04e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RHOA—stomach cancer	1.76e-05	7.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CD44—stomach cancer	1.76e-05	7.04e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOS3—stomach cancer	1.74e-05	6.97e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CA—stomach cancer	1.74e-05	6.96e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTP1—stomach cancer	1.73e-05	6.93e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO1—stomach cancer	1.73e-05	6.91e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ECHS1—stomach cancer	1.72e-05	6.9e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PDHA1—stomach cancer	1.72e-05	6.9e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTT1—stomach cancer	1.72e-05	6.89e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HMOX1—stomach cancer	1.71e-05	6.84e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6R—stomach cancer	1.71e-05	6.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.71e-05	6.83e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CAV1—stomach cancer	1.71e-05	6.83e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.7e-05	6.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOA1—stomach cancer	1.7e-05	6.81e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAV1—stomach cancer	1.7e-05	6.81e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOA1—stomach cancer	1.7e-05	6.79e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—stomach cancer	1.68e-05	6.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK1—stomach cancer	1.68e-05	6.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—stomach cancer	1.68e-05	6.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RHOA—stomach cancer	1.67e-05	6.69e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	1.66e-05	6.64e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.66e-05	6.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SMAD4—stomach cancer	1.64e-05	6.54e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—stomach cancer	1.63e-05	6.52e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.63e-05	6.5e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRKCB—stomach cancer	1.63e-05	6.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FADS1—stomach cancer	1.62e-05	6.48e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMP—stomach cancer	1.62e-05	6.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6ST—stomach cancer	1.62e-05	6.47e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	1.62e-05	6.47e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.62e-05	6.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO1—stomach cancer	1.61e-05	6.46e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TYMS—stomach cancer	1.61e-05	6.45e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—stomach cancer	1.61e-05	6.44e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	1.6e-05	6.41e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	1.6e-05	6.4e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTM1—stomach cancer	1.59e-05	6.37e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.59e-05	6.35e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KRAS—stomach cancer	1.58e-05	6.33e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APC—stomach cancer	1.56e-05	6.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FYN—stomach cancer	1.55e-05	6.21e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL8—stomach cancer	1.55e-05	6.18e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RHOA—stomach cancer	1.54e-05	6.17e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—stomach cancer	1.54e-05	6.16e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—stomach cancer	1.54e-05	6.14e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CD44—stomach cancer	1.53e-05	6.13e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOS3—stomach cancer	1.53e-05	6.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SREBF2—stomach cancer	1.52e-05	6.07e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	1.51e-05	6.04e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—RORA—stomach cancer	1.5e-05	6e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ERCC2—stomach cancer	1.5e-05	5.99e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—stomach cancer	1.5e-05	5.99e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.5e-05	5.98e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	1.49e-05	5.96e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—stomach cancer	1.47e-05	5.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—stomach cancer	1.47e-05	5.88e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTP1—stomach cancer	1.47e-05	5.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGFR2—stomach cancer	1.46e-05	5.83e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	1.46e-05	5.82e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HMOX1—stomach cancer	1.45e-05	5.79e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6R—stomach cancer	1.44e-05	5.78e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—stomach cancer	1.44e-05	5.76e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUN—stomach cancer	1.44e-05	5.75e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD44—stomach cancer	1.43e-05	5.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—stomach cancer	1.43e-05	5.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	1.42e-05	5.67e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—stomach cancer	1.42e-05	5.67e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MTHFR—stomach cancer	1.41e-05	5.63e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALDOB—stomach cancer	1.41e-05	5.62e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—stomach cancer	1.4e-05	5.59e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	1.39e-05	5.57e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.39e-05	5.56e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TYMS—stomach cancer	1.36e-05	5.46e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK8—stomach cancer	1.36e-05	5.44e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—stomach cancer	1.36e-05	5.42e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.35e-05	5.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	1.35e-05	5.41e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—stomach cancer	1.35e-05	5.39e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—stomach cancer	1.35e-05	5.38e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—stomach cancer	1.35e-05	5.38e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—stomach cancer	1.34e-05	5.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IRS2—stomach cancer	1.33e-05	5.34e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	1.32e-05	5.29e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.31e-05	5.23e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RHOA—stomach cancer	1.3e-05	5.22e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.3e-05	5.21e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAV1—stomach cancer	1.3e-05	5.19e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOA1—stomach cancer	1.3e-05	5.18e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CAV1—stomach cancer	1.29e-05	5.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—stomach cancer	1.29e-05	5.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOA1—stomach cancer	1.29e-05	5.16e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—stomach cancer	1.29e-05	5.15e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—stomach cancer	1.29e-05	5.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DPYD—stomach cancer	1.29e-05	5.14e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—stomach cancer	1.28e-05	5.11e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ERCC2—stomach cancer	1.27e-05	5.07e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—stomach cancer	1.26e-05	5.05e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—stomach cancer	1.26e-05	5.04e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—stomach cancer	1.26e-05	5.04e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—stomach cancer	1.26e-05	5.02e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—stomach cancer	1.24e-05	4.97e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCB—stomach cancer	1.23e-05	4.93e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.23e-05	4.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6ST—stomach cancer	1.23e-05	4.91e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—stomach cancer	1.23e-05	4.9e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	1.22e-05	4.88e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.22e-05	4.87e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—stomach cancer	1.21e-05	4.83e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—stomach cancer	1.19e-05	4.78e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—stomach cancer	1.19e-05	4.77e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—stomach cancer	1.19e-05	4.77e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TYMS—stomach cancer	1.19e-05	4.75e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—stomach cancer	1.19e-05	4.75e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—stomach cancer	1.18e-05	4.71e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—stomach cancer	1.18e-05	4.71e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—stomach cancer	1.18e-05	4.71e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—stomach cancer	1.18e-05	4.7e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—stomach cancer	1.15e-05	4.62e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—stomach cancer	1.15e-05	4.58e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—stomach cancer	1.14e-05	4.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—stomach cancer	1.14e-05	4.55e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.14e-05	4.55e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—stomach cancer	1.13e-05	4.52e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—stomach cancer	1.13e-05	4.52e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—stomach cancer	1.13e-05	4.51e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.12e-05	4.49e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	1.12e-05	4.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TYMS—stomach cancer	1.11e-05	4.44e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ERCC2—stomach cancer	1.1e-05	4.42e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—stomach cancer	1.1e-05	4.4e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—stomach cancer	1.1e-05	4.4e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—stomach cancer	1.1e-05	4.39e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOA1—stomach cancer	1.1e-05	4.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6R—stomach cancer	1.09e-05	4.38e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.09e-05	4.37e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—stomach cancer	1.09e-05	4.36e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—stomach cancer	1.09e-05	4.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—stomach cancer	1.07e-05	4.3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—stomach cancer	1.07e-05	4.29e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—stomach cancer	1.07e-05	4.27e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—stomach cancer	1.07e-05	4.27e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO1—stomach cancer	1.07e-05	4.26e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—stomach cancer	1.06e-05	4.26e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.05e-05	4.2e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—stomach cancer	1.04e-05	4.16e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—stomach cancer	1.04e-05	4.15e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—stomach cancer	1.04e-05	4.14e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ERCC2—stomach cancer	1.03e-05	4.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	1.03e-05	4.13e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—stomach cancer	1.03e-05	4.11e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	1.03e-05	4.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—stomach cancer	1.02e-05	4.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—stomach cancer	1.01e-05	4.06e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—stomach cancer	1.01e-05	4.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—stomach cancer	1.01e-05	4.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—stomach cancer	9.91e-06	3.96e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—stomach cancer	9.9e-06	3.96e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RHOA—stomach cancer	9.89e-06	3.95e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—stomach cancer	9.82e-06	3.93e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	9.8e-06	3.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—stomach cancer	9.78e-06	3.91e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—stomach cancer	9.7e-06	3.88e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—stomach cancer	9.67e-06	3.87e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—stomach cancer	9.58e-06	3.83e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOA1—stomach cancer	9.56e-06	3.82e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—stomach cancer	9.48e-06	3.79e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD44—stomach cancer	9.45e-06	3.78e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—stomach cancer	9.36e-06	3.74e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	9.32e-06	3.73e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—stomach cancer	9.3e-06	3.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—stomach cancer	9.21e-06	3.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—stomach cancer	9.15e-06	3.66e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—stomach cancer	9.07e-06	3.63e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—stomach cancer	8.98e-06	3.59e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—stomach cancer	8.95e-06	3.58e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOA1—stomach cancer	8.93e-06	3.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—stomach cancer	8.8e-06	3.52e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—stomach cancer	8.69e-06	3.48e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—stomach cancer	8.68e-06	3.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—stomach cancer	8.68e-06	3.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—stomach cancer	8.62e-06	3.45e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	8.6e-06	3.44e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—stomach cancer	8.56e-06	3.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.55e-06	3.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	8.48e-06	3.39e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—stomach cancer	8.42e-06	3.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—stomach cancer	8.37e-06	3.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—stomach cancer	8.37e-06	3.35e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—stomach cancer	8.32e-06	3.33e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—stomach cancer	8.31e-06	3.33e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—stomach cancer	8.25e-06	3.3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—stomach cancer	8.09e-06	3.23e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—stomach cancer	8.07e-06	3.23e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.03e-06	3.21e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—stomach cancer	7.95e-06	3.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—stomach cancer	7.91e-06	3.16e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—stomach cancer	7.88e-06	3.15e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—stomach cancer	7.87e-06	3.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—stomach cancer	7.85e-06	3.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	7.82e-06	3.13e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—stomach cancer	7.77e-06	3.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—stomach cancer	7.63e-06	3.05e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—stomach cancer	7.61e-06	3.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—stomach cancer	7.6e-06	3.04e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—stomach cancer	7.57e-06	3.03e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMS—stomach cancer	7.32e-06	2.93e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	7.26e-06	2.91e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—stomach cancer	7.24e-06	2.9e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—stomach cancer	7.24e-06	2.9e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—stomach cancer	7.24e-06	2.9e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—stomach cancer	7.07e-06	2.83e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—stomach cancer	7.05e-06	2.82e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—stomach cancer	7.03e-06	2.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—stomach cancer	6.98e-06	2.79e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ERCC2—stomach cancer	6.81e-06	2.72e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—stomach cancer	6.77e-06	2.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—stomach cancer	6.72e-06	2.69e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—stomach cancer	6.67e-06	2.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—stomach cancer	6.62e-06	2.65e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—stomach cancer	6.49e-06	2.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—stomach cancer	6.43e-06	2.57e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—stomach cancer	6.4e-06	2.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—stomach cancer	6.34e-06	2.54e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—stomach cancer	6.34e-06	2.54e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—stomach cancer	6.19e-06	2.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—stomach cancer	5.99e-06	2.4e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—stomach cancer	5.9e-06	2.36e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOA1—stomach cancer	5.89e-06	2.36e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—stomach cancer	5.53e-06	2.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	5.51e-06	2.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—stomach cancer	5.33e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—stomach cancer	5.19e-06	2.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—stomach cancer	5.09e-06	2.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—stomach cancer	4.88e-06	1.95e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—stomach cancer	4.68e-06	1.87e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—stomach cancer	4.67e-06	1.87e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—stomach cancer	4.46e-06	1.78e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—stomach cancer	4.08e-06	1.63e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—stomach cancer	4.08e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—stomach cancer	3.81e-06	1.52e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.51e-06	1e-05	CbGpPWpGaD
